Skip to content

Author

H. Carroll

We have 2 of 12 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Efficacy and safety of litifilimab in cutaneous lupus erythematosus: 24-week results of the randomized phase 2 study, AMETHYST.

BACKGROUND Cutaneous lupus erythematosus (CLE) is a serious autoimmune disease with no approved targeted treatments. OBJECTIVE Evaluate the efficacy and safety of litifilimab in AMETHYST Part A (Phase 2). METHODS AMETHYST is a randomized, double-blind, placebo-controlled, Phase 2/3 study that investigates litifilim...

J. Merola, Victoria P. Werth, B. Chong et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.